How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Monday - Friday, 6:00 - 9:00 AM ET United States Monday - Friday 6a ET Europe Monday - Friday 13:00 CET Asia Monday - Friday 18:00 SIN/HK Australia Monday - Friday 20:00 SYD "Squawk Box" is the ...
Recursion Pharmaceuticals to update on FDA trial design for REC-4881 for FAP in the second half of 2026. Analysts expect potential upside from rare diseases.